199 related articles for article (PubMed ID: 5416204)
1. Combined ascitic-fluid and furosemide infusion in the management of ascites.
Eknoyan G; Martinez-Maldonado M; Yium JJ; Suki WN
N Engl J Med; 1970 Mar; 282(13):713-7. PubMed ID: 5416204
[No Abstract] [Full Text] [Related]
2. [Experience in the treatment of diuretic-resistant ascites in liver cirrhosis by intravenous infusion of autogenous ascitic fluid].
Matsuoka K; Ueda Y; Kimura M; Mashiba Y; Kitsuki K
Naika; 1971; 28(1):163-7. PubMed ID: 5565686
[No Abstract] [Full Text] [Related]
3. Combined ascitic--fluid and furosemide infusion: a therapeutic option for massive diuretic-resistant ascites and severe oliguria of hepatic cirrhosis.
Onuigbo MA; Ozoh JO; Nusiem CA; Onyeagocha AC; Nwaneri O; Offodile AA; Ijoma CK
Cent Afr J Med; 1991 Aug; 37(8):244-7. PubMed ID: 1807797
[TBL] [Abstract][Full Text] [Related]
4. [Effect of furosemide combined with reinfusion of ascitic fluid in hepatic cirrhosis with refractory ascites and changes in renal function].
Bardi A; Orozco R; Fernandez I
Rev Med Chil; 1973 May; 101(5):382-7. PubMed ID: 4755002
[No Abstract] [Full Text] [Related]
5. Use of a new diuretic agent (metolazone) in patients with edema and ascites.
Lowenthal DT; Shear L
Arch Intern Med; 1973 Jul; 132(1):38-41. PubMed ID: 4716425
[No Abstract] [Full Text] [Related]
6. Are ascitic electrolytes usable in cirrhotic patients? Correlation of sodium, potassium, chloride, urea, and creatinine concentrations in ascitic fluid and blood.
Nguyen-Khac E; Thevenot T; Capron D; Dharancy S; Paupart T; Thabut D; Tiry C
Eur J Intern Med; 2008 Dec; 19(8):613-8. PubMed ID: 19046728
[TBL] [Abstract][Full Text] [Related]
7. Development of renal impairment in Laennec's cirrhosis.
Mullane JF; Gliedman ML
Ann Surg; 1971 Dec; 174(6):892-901. PubMed ID: 5316206
[No Abstract] [Full Text] [Related]
8. [Experience in the treatment of water-salt retentions in cirrhosis by the antialdosterone 11614 R.P].
Boivin P; Fauvert R
Rev Int Hepatol; 1969; 19(4):241-51. PubMed ID: 5404532
[No Abstract] [Full Text] [Related]
9. Letter: Treatment of ascites.
Naccarato R; Sturniolo GC; Farini R; D'Angelo A; Ossi E
Lancet; 1974 Nov; 2(7890):1213. PubMed ID: 4139635
[No Abstract] [Full Text] [Related]
10. Hepatorenal syndrome: study of clinical characteristics in a large series.
Bern MM
South Med J; 1973 Jul; 66(7):775-8. PubMed ID: 4543096
[No Abstract] [Full Text] [Related]
11. [Refractory hepatic cirrosis and the ineffectiveness of diuretics in ascites and edema].
Inoue J; Mori Y; Kawamura T
Naika; 1969 Nov; 24(5):834-9. PubMed ID: 4902224
[No Abstract] [Full Text] [Related]
12. [Drying of cirrhotic ascites by continuous intravenous reinjection of concentrated ascitic fluid].
Lévy VG; Hecht Y; Georgacopoulos H; Hadchouel P; Touboul JP; Sausse A; Granger A; Stern A; Caroli J
Ann Med Interne (Paris); 1971 Nov; 122(11):1075-85. PubMed ID: 5150308
[No Abstract] [Full Text] [Related]
13. High doses of spironolactone (Aldactone, SC-14266, Verospirone) alone and in combination with triamterene and-or diuretics in the treatment of refractory edema associated with secondary hyperaldosteronism.
Radó JP; Marosi J; Takó J
Endokrinologie; 1970; 57(1):46-62. PubMed ID: 4923990
[No Abstract] [Full Text] [Related]
14. [The significance of urine sodium measurement after furosemide administration in diuretics-unresponsive patients with liver cirrhosis].
Cho HS; Park GT; Kim YH; Shim SG; Kim JB; Lee OY; Choi HS; Hahm JS; Lee MH
Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):324-31. PubMed ID: 14695699
[TBL] [Abstract][Full Text] [Related]
15. Renal concentrating ability in cirrhosis. I. Changes associated with the clinical status and course of the disease.
Vaamonde CA; Vaamonde LS; Morosi HJ; Klingler EL; Papper S
J Lab Clin Med; 1967 Aug; 70(2):179-94. PubMed ID: 6029052
[No Abstract] [Full Text] [Related]
16. [Preliminary observations on the use of the method of extraction, concentration and reinfusion of ascitic fluid in cirrhotic patients].
Fiaccadori F; Aurier E; Ghinelli F; Pelosi G; Pizzaferri A; Pizzigoni G; Sgobba G
Ateneo Parmense Acta Biomed; 1974; 45(4-5):257-70. PubMed ID: 4451577
[No Abstract] [Full Text] [Related]
17. Intravascular, interstitial and intracellular phase changes during acute furosemide or ethacrynic acid diuresis.
Olesen KH
Isr J Med Sci; 1969; 5(4):942-6. PubMed ID: 5820551
[No Abstract] [Full Text] [Related]
18. Comparative pharmacodynamics of furosemide and muzolimine in cirrhosis. Study on renal sodium and potassium handling and renin-aldosterone axis.
Bernardi M; De Palma R; Trevisani F; Santini C; Servadei D; Gasbarrini G
Z Kardiol; 1985; 74 Suppl 2():129-34. PubMed ID: 3890391
[TBL] [Abstract][Full Text] [Related]
19. Clinical experience with furosemide.
Herrmann GR; Ghiselli RG
South Med J; 1968 Oct; 61(10):1083-8. PubMed ID: 5746300
[No Abstract] [Full Text] [Related]
20. [Reinfusion treatment of therapy-resistant ascites. Preliminary experiences with a new method (author's transl)].
Isliker K; Filippini L
Dtsch Med Wochenschr; 1974 May; 99(20):1061-3. PubMed ID: 4834764
[No Abstract] [Full Text] [Related]
[Next] [New Search]
